These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 33615747)
21. Outcome of ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry. Lang H; de Santibanes E; Clavien PA HPB (Oxford); 2017 May; 19(5):379-380. PubMed ID: 28262523 [No Abstract] [Full Text] [Related]
22. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296 [TBL] [Abstract][Full Text] [Related]
23. Descriptive epidemiology of bile duct carcinoma in Osaka. Ikeda A; Miyashiro I; Nakayama T; Ioka A; Tabuchi T; Ito Y; Tsukuma H Jpn J Clin Oncol; 2013 Nov; 43(11):1150-5. PubMed ID: 24014885 [TBL] [Abstract][Full Text] [Related]
24. The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry. Satake T; Morizane C; Rikitake R; Higashi T; Okusaka T; Kawai A J Gastroenterol; 2022 Nov; 57(11):890-901. PubMed ID: 36161533 [TBL] [Abstract][Full Text] [Related]
25. ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma. Bagante F; Pawlik TM Ann Surg Oncol; 2018 Dec; 25(Suppl 3):784-785. PubMed ID: 30288652 [No Abstract] [Full Text] [Related]
26. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748 [TBL] [Abstract][Full Text] [Related]
27. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification. Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117 [TBL] [Abstract][Full Text] [Related]
28. Regulators of apoptosis in cholangiocarcinoma. Jhala NC; Vickers SM; Argani P; McDonald JM Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670 [TBL] [Abstract][Full Text] [Related]
29. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise. Saha SK; Zhu AX; Fuchs CS; Brooks GA Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463 [TBL] [Abstract][Full Text] [Related]
30. Cholangiocarcinoma at the hepatic hilus: sonographic findings. Hann LE; Greatrex KV; Bach AM; Fong Y; Blumgart LH AJR Am J Roentgenol; 1997 Apr; 168(4):985-9. PubMed ID: 9124155 [TBL] [Abstract][Full Text] [Related]
31. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis. Yan Y; Lu N; Tian W; Liu T Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507 [TBL] [Abstract][Full Text] [Related]
32. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis. Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837 [TBL] [Abstract][Full Text] [Related]
33. Incidence, Mortality, and Survival Trends in Cancer of the Gallbladder and Extrahepatic Bile Ducts in Lithuania. Dulskas A; Cerkauskaite D; Patasius A; Smailyte G Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109618 [No Abstract] [Full Text] [Related]
34. Liver transplantation for intra- and extrahepatic cholangiocarcinoma. Schmeding M; Neumann UP Ann Transplant; 2013 Jan; 18():1-8. PubMed ID: 23792495 [TBL] [Abstract][Full Text] [Related]
35. Current epidemiology of cholangiocarcinoma in Western countries. Vithayathil M; Khan SA J Hepatol; 2022 Dec; 77(6):1690-1698. PubMed ID: 35977611 [TBL] [Abstract][Full Text] [Related]